Study finds bacteria may reduce risk for kidney stones

Researchers from Boston University’s Slone Epidemiology Center have
found that the bacteria Oxalobacter formigenes (O. formigenes), a
naturally occurring bacterium that has no known side effects, is
associated with a 70 percent reduction in the risk of recurrent kidney
stones. These findings appear online in the March issue Journal of the
American Society of Nephrology.

Kidney stones are an important health problem in many countries. In
the United States, the lifetime risk for developing a stone is five to
15 percent, and a five-year risk for recurrence is 30 to 50 percent.
The economic impact of hospital admissions for this condition is $2
billion per year.

According to the researchers, up to 80 percent of kidney stones are
predominately composed on calcium oxalate (CaOx) and urinary oxalate
is a major risk factor for CaOx stone formation. O. formigenes
metabolizes oxalate in the intestinal tract and is present in a large
proportion of the normal adult population.

Data was collected in the Boston, Massachusetts and Durham, North
Carolina areas from 247 adult patients with recurrent CaOx stones and
compared with 259 age, sex, and region-matched controls. O. formigenes
colonization was determined by culture of stool samples. Information
was obtained by interview and self-administered dietary questionnaire.
24-hour oxalate excretion and other urinary risk factors were measured
in a subset of 139 cases and 138 controls. The prevalence of O.
formigenes was 17 percent among cases and 38 percent among controls,
giving an odds ration of 0.3. The finding was consistent in subgroups
defined according to age, sex, race, region and antibiotic use.

“We observed a strong inverse association between colonization with O.
formigenes and recurrent CaOx kidney stones, with a 70 percent
reduction in overall risk,” said lead researcher David Kaufman, ScD, a
professor of epidemiology at Boston University School of Public
Health. “Our findings are of potential clinical importance. The
possibility of using the bacterium as a probiotic is currently in the
early stages of investigation,” added Kaufman.

Source: Boston University

ARTICLE LINK:
http://www.physorg.com/news123944082.html